307 related articles for article (PubMed ID: 16797494)
1. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
[TBL] [Abstract][Full Text] [Related]
2. The herbal medicine, Dai-Kenchu-to, accelerates delayed gastrointestinal transit after the operation in rats.
Fukuda H; Chen C; Mantyh C; Ludwig K; Pappas TN; Takahashi T
J Surg Res; 2006 Apr; 131(2):290-5. PubMed ID: 16259999
[TBL] [Abstract][Full Text] [Related]
3. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
Neyens R; Jackson KC
J Pain Palliat Care Pharmacother; 2007; 21(2):27-33. PubMed ID: 17844725
[TBL] [Abstract][Full Text] [Related]
4. Current choices--good or bad--for the proactive management of postoperative ileus: A surgeon's view.
Saclarides TJ
J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S7-15. PubMed ID: 16597534
[TBL] [Abstract][Full Text] [Related]
5. Off-label uses of alvimopan and methylnaltrexone.
Rodriguez RW
Am J Health Syst Pharm; 2014 Sep; 71(17):1450-5. PubMed ID: 25147168
[TBL] [Abstract][Full Text] [Related]
6. Alvimopan and COX-2 inhibition reverse opioid and inflammatory components of postoperative ileus.
Schmidt J; Stoffels B; Nazir A; Dehaven-Hudkins DL; Bauer AJ
Neurogastroenterol Motil; 2008 Jun; 20(6):689-99. PubMed ID: 18266613
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of sympathetic pathways restores postoperative ileus in the upper and lower gastrointestinal tract.
Fukuda H; Tsuchida D; Koda K; Miyazaki M; Pappas TN; Takahashi T
J Gastroenterol Hepatol; 2007 Aug; 22(8):1293-9. PubMed ID: 17688668
[TBL] [Abstract][Full Text] [Related]
8. Emerging pharmacologic options for treating postoperative ileus.
Kraft MD
Am J Health Syst Pharm; 2007 Oct; 64(20 Suppl 13):S13-20. PubMed ID: 17909271
[TBL] [Abstract][Full Text] [Related]
9. Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus.
Kraft MD
Expert Opin Investig Drugs; 2008 Sep; 17(9):1365-77. PubMed ID: 18694369
[TBL] [Abstract][Full Text] [Related]
10. Alvimopan for the management of postoperative ileus.
Leslie JB
Ann Pharmacother; 2005 Sep; 39(9):1502-10. PubMed ID: 16076918
[TBL] [Abstract][Full Text] [Related]
11. Peripherally acting mu-opioid-receptor antagonists and the connection between postoperative ileus and pain management: The anesthesiologist's view and beyond.
Sinatra RS
J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S16-23. PubMed ID: 16597531
[TBL] [Abstract][Full Text] [Related]
12. Alvimopan* (ADL 8-2698) is a novel peripheral opioid antagonist.
Schmidt WK
Am J Surg; 2001 Nov; 182(5A Suppl):27S-38S. PubMed ID: 11755894
[TBL] [Abstract][Full Text] [Related]
13. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
Becker G; Blum HE
Lancet; 2009 Apr; 373(9670):1198-206. PubMed ID: 19217656
[TBL] [Abstract][Full Text] [Related]
14. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability.
Viscusi ER; Gan TJ; Leslie JB; Foss JF; Talon MD; Du W; Owens G
Anesth Analg; 2009 Jun; 108(6):1811-22. PubMed ID: 19448206
[TBL] [Abstract][Full Text] [Related]
15. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.
Wolff BG; Michelassi F; Gerkin TM; Techner L; Gabriel K; Du W; Wallin BA;
Ann Surg; 2004 Oct; 240(4):728-34; discussion 734-5. PubMed ID: 15383800
[TBL] [Abstract][Full Text] [Related]
16. The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor.
DeHaven-Hudkins DL; DeHaven RN; Little PJ; Techner LM
Pharmacol Ther; 2008 Jan; 117(1):162-87. PubMed ID: 18022696
[TBL] [Abstract][Full Text] [Related]
17. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study.
Viscusi ER; Goldstein S; Witkowski T; Andonakakis A; Jan R; Gabriel K; Du W; Techner L; Wallin B
Surg Endosc; 2006 Jan; 20(1):64-70. PubMed ID: 16333556
[TBL] [Abstract][Full Text] [Related]
18. Alvimopan, a selective peripherally acting mu-opioid antagonist.
Camilleri M
Neurogastroenterol Motil; 2005 Apr; 17(2):157-65. PubMed ID: 15787936
[TBL] [Abstract][Full Text] [Related]
19. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies.
Delaney CP; Wolff BG; Viscusi ER; Senagore AJ; Fort JG; Du W; Techner L; Wallin B
Ann Surg; 2007 Mar; 245(3):355-63. PubMed ID: 17435541
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study.
Büchler MW; Seiler CM; Monson JR; Flamant Y; Thompson-Fawcett MW; Byrne MM; Mortensen ER; Altman JF; Williamson R
Aliment Pharmacol Ther; 2008 Aug; 28(3):312-25. PubMed ID: 19086236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
